Request for Proposals - 2023-2025 Strategy and Implementation Plan

Request for proposals – Development of the Medicines Patent Pool’s 2023-2025 organisational strategy and implementation plan

1. Overview

The Medicines Patent Pool (MPP)’s five-year strategic plan, which supports its mission of increasing access to, and facilitating the development of, life-saving medicines for low- and middle-income countries (LMICs) will expire at the end of 2022. MPP is therefore accepting proposals to support the development of its new 2023-2025 organisational strategy and implementation plan.

The duration for this consultancy is defined for a period of approximately 18 months. The work should start on 15 June 2021 (or as soon as the procurement process is completed) and will end in October 2022 when the deliverables have been formally approved by the MPP Governance Board at the Autumn Board meeting. The consultancy will be conducted under the overall guidance of the MPP Executive Director and Head of Strategy, Operations and Resource Mobilisation. During the consultancy, the selected consultants will be working in close collaboration with MPP’s Senior Management Team (SMT).

2. About the Medicines Patent Pool

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to, and facilitate the development of, life-saving medicines for low- and middle-income countries.

Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders, to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.

To date, MPP has signed agreements with ten patent holders for thirteen HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals and a tuberculosis treatment. MPP was founded by Unitaid, which serves as sole funder for MPP’s activities in HIV, hepatitis C and tuberculosis. Figures at the end of 2020 show that the international community has saved 1.96 billion dollars and that 18.55 billion doses of treatment have been supplied as a direct result of MPP’s interventions.

MPP was founded by Unitaid in 2010, which serves as sole funder for MPP’s activities in HIV, hepatitis C and tuberculosis. Activities in the context of other patented essential medicines are co-funded by Unitaid and the Swiss Agency for Development and Cooperation until the end of 2022.

For more information

3. Scope of work and deliverables

MPP will require consultancy support throughout the whole process of designing the 2023-2025 organisational strategy and implementation plan. Three key development phases have been identified as outlined below and a tentative timeline has also been suggested. MPP welcomes informed feedback and suggestions on the flow of the process.

> Phase 1: Setting the scene (timeline: June 2021 to November 2021)

  • MPP is over halfway through the implementation of its existing strategy. As such, the first step of the process will be to conduct a formal strategy review and identify key learnings from the period in close collaboration with MPP’s SMT.
  • A landscape analysis to understand how the environment in which MPP operates has evolved particularly vis-à-vis the COVID-19 pandemic will also need to be completed and implications for the next strategic period identified.
  • Finally, Unitaid is currently conducting an evaluation of their recently concluded 5-year grant to MPP spanning 2016-2020, which includes a stakeholder consultation. Two forward-looking questions have been included in the set of interview questions, the outcome of which will have to be combined with all other elements to form a set of strategic options to be evaluated and considered in the development of the strategic framework and implementation plan. An informal consultation will also take place with the wider MPP team, former members of the Governance Board and follow-up interviews with selected external stakeholders may be considered. The Unitaid Evaluation Report will be available.

Deliverables:

  • Report of the strategy review highlighting key learnings
  • Landscape analysis and implications for strategy
  • Synthesis and analysis of all elements resulting from the strategy review, landscape analysis and outcome of stakeholder consultation resulting in a set of strategic options

 

> Phase 2: Strategic framework / Implementation planning (timeline: December 2021 to June 2022)

  • Refine the strategic options identified in the first phase and develop a tentative framework, which is anticipated to be the basis for discussion at a Board strategic retreat, provisionally set for June 2022.
  • Governance Board strategic retreat:
    • Support the preparation of strategic and technical background documents and agenda for the retreat in close collaboration with MPP’s SMT.
    • Facilitate the Board retreat that will take place, by ensuring a smooth meeting, that the agenda points are covered and the decisions toward strategy operationalisation and prioritisation are made and outcomes recorded.
    • Ensure good group dynamics and provide tools to facilitate informed decision-making by the Board.
  • Develop a preliminary implementation plan.

Deliverables:

  • Draft strategic framework
  • Board strategic retreat
  • Preliminary implementation plan

 

> Finalisation and launch (timeline: July 2022 to December 2022)

  • Integrate the outcome of the Board discussions at the strategic retreat into the initial draft of the strategic framework and finalise both the strategy document and the implementation plan.
  • Evaluate MPP’s ability to deliver the strategy and identify any required tools or additional capacities.

Deliverables:

  • Final strategy document including an executive summary and consolidated implementation plan 

Note that communications activities including the launch of the strategy will be carried out by MPP’s Communications team and is not within the scope of this consultancy.

 

4. Estimated requirements, expertise and qualifications

The consultant should be a public institution, a company, an international consulting group, or other type of organisation or an individual with proven expertise in:

  • Strategy development
  • Corporate Governance
  • Strategic and operational planning
  • Organisational performance improvement
  • Partnership management

The consultant should also have the following skills:

  • Excellent strategy development knowledge, skills and experience
  • Experience in designing group processes to enable maximum participation in support of the retreat’s agreed purpose; knowledge of a range of participatory and other methods; experience of facilitating and working with complex issues and dynamics; ability to work ‘in the moment’ with flexibility and creativity as needed.
  • A collaborative approach with excellent communication and interpersonal skills.
  • Experience in working with non-profit or international organisations.
  • Experience in partnerships (public-private).
  • First-hand knowledge and experience of public health issues and global health institutions.
  • An ability to facilitate with objectivity.

Proposals will be assessed against those criteria.

 

5. Proposal content/structure

Prospective service providers are asked to submit two proposals: one for the whole of the work outlined in section 3 and one excluding the work relating to the implementation plan.

Proposal should include the following sections and elements:

Section 1:  Technical

  • The methodology and work plan for addressing the functional requirements set out in the terms of reference. This should include a tentative schedule of the activities outlining the timelines for major action
  • Staff dedicated to the project, with lead identified
  • Expertise of staff involved
  • CV of the staff
  • Particular expertise of the bidder with regards to the objectives of the terms of reference
  • Quality assurance methodology

 

Section 2: Profile of the bidder

  • Location
  • Status (Public Institution, University, Private Company, Individual etc.)
  • Company profile (main activities/services, areas of expertise)
  • Excellent spoken and written English
  • Statement of relevant experience (incl. key clients)
  • Previous experience with global health organisation
  • Code of conduct
  • Declaration of non-conflict of interest

MPP reserves the right to contact key clients for reference.

 

Section 3: Financial / cost

The bidder is asked to provide a comprehensive and detailed budget to be evaluated in either CHF or USD. They should include the breakdown by categories shown in the table below, with detailed costing assumptions provided (unit cost, number of units, etc). Travel costs should be estimated according to an ideal scenario as defined by prospective service providers.

6. Process of Request for Proposal (RFP)

Proposals and requests for additional information regarding this RFP must be submitted by email to Karine Belondrade, Head of Strategy, Operations and Resource Mobilisation at kbelondrade@medicinespatentpool.org. The deadline for submission of proposals in response to this RFP is Monday 17 May. Please note that MPP may decide to extend the period to receive proposals, if deemed necessary by MPP.

MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders

This website uses cookies to ensure you get the best experience on our website. Learn More